News on Medial

Tvaster Genkalp raises $1.25 Mn in pre-Series A round

Entrackr · 1d

Title: Tvaster Genkalp raises $1.25 Mn in pre-Series A round Healthtech startup Tvaster Genkalp has raised $1.25 million in its pre-Series A round led by Ideaspring Capital. Existing backers such as Invigo Softwares and liver transplant expert Prof. Mohamed Rela also joined the round. The proceeds will be used to help expand and market Episcreen™ Liver, a new blood test that can detect liver cancer early with 90% accuracy. This test offers a better option than the current standard, Alpha-Fetoprotein (AFP), which has only 50% sensitivity. Founded in 2021 by Dr. Srikar Raman and K. Sreedurgalakshmi, Tvaster is building high-accuracy, non-invasive tests for cancer. It aims to improve early detection and save lives, especially for liver cancer, which affects over 900,000 people globally every year. Tvaster has tested Episcreen™ Liver on over 600 patients and plans to partner with top diagnostic labs for wider access. The firm is also working on tests for bile duct cancer and childhood liver cancer treatment resistance. It recently won the ILTS Young Researcher Award and received a BIRAC BIG Grant for its work in cancer diagnostics.